Policy Statement on the Role of Dentistry in the Treatment of Sleep Related Breathing Disorders

Sleep related breathing disorders (SRBD) are disorders characterized by disruptions in normal breathing patterns. SRBDs are potentially serious medical conditions caused by anatomical airway collapse and altered respiratory control mechanisms. Common SRBDs include snoring, upper airway resistance syndrome (UARS) and obstructive sleep apnea (OSA). OSA has been associated with metabolic, cardiovascular, respiratory, dental and other […]

Read More
The Relationship Between Primary Sleep Disorders and Temporomandibular Disorders

The Relationship Between Primary Sleep Disorders and Temporomandibular Disorders

Background: While evidence is accumulating to propose a specific contribution of sleep disorders and low quality sleep in the pathogenesis of temporomandibular disorders (TMD), management of primary sleep disorders in the process of preventing and treating TMD still remains scientifically unsupported. Objective: To investigate the association of primary sleep disorders with TMD risk in South Korea. Patients […]

Read More
Modifications in Upper Airway Collapsibility during Sleep Endoscopy with a Mandibular Positioner

Modifications in Upper Airway Collapsibility during Sleep Endoscopy with a Mandibular Positioner

Abstract Background: Mandibular advancement devices (MADs) are an effective treatment for patients with sleep-related breathing disorders, with variable response. Increasingly more research points to the predictive value of Drug-Induced Sleep Endoscopy (DISE) in patient selection. This study aims to analyze the changes in upper airway collapsibility using a titratable MAD simulator during DISE. Methods: This […]

Read More

Mandibular advancement devices (MAD)

Mandibular advancement devices (MAD) are noninferior to continuous positive airway pressure (CPAP) for lowering mean arterial blood pressure (MABP) in patients with moderate-to-severe obstructive sleep apnea (OSA), according to results from the CRESCENT trial presented during a Featured Clinical Research session at ACC.24 and simultaneously published in JACC. The noninferiority trial, conducted from October 2019 [...]
Read More